IRLAB's Drug Candidates IRL942 and IRL1009 Have Been Granted Patents in the US and Europe PR Newswire STOCKHOLM, Nov. 6, 2019 STOCKHOLM, Nov. 6...
IRLAB Presents at the 2019 International Congress of Parkinson's Disease and Movement Disorders PR Newswire STOCKHOLM, Sept. 23, 2019 STOCKHOLM...
IRLAB to Advance Clinical Development of IRL790 in LIDs Based on In-depth Analysis of Positive Phase IIa Results PR Newswire STOCKHOLM, Aug. 28...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.